Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-07-26FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for FYCOMPA (perampanel) submitted by Eisai Inc. The action expands the product's labeling to reflec…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) [Phase 4]
A Phase 4 clinical trial (EQUIGEN Single-Dose Study) evaluates the bioequivalence of generic and brand antiepileptic drugs in people with ep…
-
CLINICAL_TRIALS research · 2017-07-18Clinical Trial Update: Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients [Phase 2]
This document describes a Phase 2 trial protocol to prevent lamotrigine-induced skin rash in patients with epilepsy. The study is being deve…
-
CLINICAL_TRIALS withdrawal · 2017-07-18Clinical Trial Update: Computerized Cognitive Training in Epilepsy [NA]
The NYU Langone Health-sponsored trial evaluating computerized cognitive training for epilepsy has been withdrawn.
-
CLINICAL_TRIALS research · 2017-07-17Clinical Trial Update: Dietary Therapy In Epilepsy Treatment (DIET-Trial): A Randomised Non Inferiority Trial Comparing KD, MAD & LGIT for Drug Resistant Epilepsy [NA]
This update describes the DIET-Trial, a randomized non-inferiority trial comparing three dietary therapies—Ketogenic Diet (KD), Modified Atk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: TAK-935 Multiple Rising Dose Study in Healthy Participants [Phase 1]
Takeda's TAK-935 Phase 1 multiple rising dose study in healthy participants has completed and results were posted in July 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Seizure Detection and Warning System in Epilepsy Patients
The Brain Sentinel seizure detection and warning system clinical trial for epilepsy patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients [Phase 4]
A Phase 4 tolerability study of vigabatrin (Sabril) for complex partial seizures was terminated; results were posted in 2017.
-
EMA safety_alert · 2017-07-11EMA seeks views of public during its safety review of valproate
EMA is seeking public input as part of its safety review of valproate, focusing on potential risks and safer use to protect patients, partic…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction? [NA]
A completed clinical trial assessed memantine for improving verbal memory in individuals with partial epilepsy and memory dysfunction. Resul…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings
This completed clinical trial evaluated synchronized MEG-EEG recordings as a non-invasive method to localize seizures in patients with local…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
An update on a completed clinical trial investigating how hormones influence seizure susceptibility in women with epilepsy. The study status…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Reducing Seizure Frequency Using Cooling of the Head and Neck [Phase 2]
A Phase 2 clinical trial assessing cooling of the head and neck to reduce seizure frequency in epilepsy has completed.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Neuropsychological Evaluation of Psychiatric and Neurological Patients
ClinicalTrials.gov entry describing a completed neuropsychological evaluation study conducted by the NIMH involving patients with anxiety di…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
This completed clinical trial investigated brain swelling and seizure activity associated with inactive cysticercosis. The update highlights…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Language and Emotional Function in Patients With Temporal Lobe Epilepsy
This clinical trial update describes language and emotional function outcomes in patients with temporal lobe epilepsy. The study, sponsored …
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Impact of Neuropsychological Evaluation on Epilepsy Treatment [Phase 2]
A Phase 2 clinical trial from the University of South Florida investigates how neuropsychological evaluation affects epilepsy treatment, but…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Topiramate Bioequivalence Study Brazil - Fast [Phase 1]
GlaxoSmithKline conducted a Phase 1 bioequivalence study of topiramate in Brazil, and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Preventing Epilepsy After Traumatic Brain Injury With Topiramate [EARLY_Phase 1]
Phase 1 trial evaluating topiramate to prevent epilepsy after traumatic brain injury was terminated early.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cannabidiol oral solution in pediatric participants with treatment-resistant seizure disorders has compl…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Bioequivalence Study of 300 mg Gabapentin [Phase 1]
A Phase 1 study evaluating the bioequivalence of 300 mg gabapentin formulations has completed.
-
FDA approval · 2017-06-16FDA Approved: FELBAMATE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved the original application for Felbamate, authorizing its generic marketing in the United States by Taro Pharmaceuticals U.S.A., …
-
FDA approval · 2017-06-16FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc., enabling its marketing as a lamotrigine-based pr…
-
FDA approval · 2017-06-09FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for levetiracetam by Prasco Laboratories, enabling a generic version to be marketed.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy [NA]
This clinical trial update reports on the efficacy, tolerability, and adherence of the Modified Atkins Diet in individuals with drug-resista…